Boštjan Šeruga

1973 -

country of citizenship: Slovenia

languages spoken, written or signed: Slovene

occupation: oncologist

Series

There is nothing here

Create a new serie

Works

There is nothing here

Create a new work

Articles 94

Date

Title

Authors

2020-01-29

Oncologist Burnout Syndrome in Eastern Europe: Results of the Multinational Survey

Boštjan Šeruga
2020-09-04

Associations between safety, tolerability, and toxicity and the reporting of health-related quality of life in phase III randomized trials in common solid tumors

Eitan Amir, Arnoud J Templeton, Boštjan Šeruga, Hadar Goldvaser
2020-07-17

Training of oncologists: results of a global survey

Boštjan Šeruga, Wilma Hopman
2019-05-21

Cancer care workforce in Africa: perspectives from a global survey

Verna Vanderpuye, Richard Sullivan, Boštjan Šeruga, Wilma Hopman, Christopher M Booth, Manju Sengar
2019-01-01

Postmarketing Safety-Related Modifications of Drugs Approved by the US Food and Drug Administration Between 1999 and 2014 Without Randomized Controlled Trials

Alberto Ocana, Boštjan Šeruga, Eitan Amir, Hadar Goldvaser, Ariadna Tibau, Daniel Shepshelovich
2019-01-02

Medical oncology job satisfaction: Results of a global survey

Richard Sullivan, Boštjan Šeruga, Wilma Hopman
2019-07-16

Medical Oncology Workload in Europe: One Continent, Several Worlds

Richard Sullivan, Alberto Ocana, Boštjan Šeruga, Wilma Hopman
2018-01-01

Toxicity of Extended Adjuvant Therapy With Aromatase Inhibitors in Early Breast Cancer: A Systematic Review and Meta-analysis.

Alberto Ocana, Boštjan Šeruga, Eitan Amir, David Cescon, Hadar Goldvaser, Domen Ribnikar, Tristan A Barnes
2018-02-08

Influence of control group therapy on the benefit from dose-dense chemotherapy in early breast cancer: a systemic review and meta-analysis

Alberto Ocana, Boštjan Šeruga, Eitan Amir, David Cescon, Hadar Goldvaser, Domen Ribnikar, Habeeb Majeed
2018-02-12

Hyperglycaemia and Survival in Solid Tumours: A Systematic Review and Meta-analysis

Alberto Ocana, J-L Ethier, Arnoud J Templeton, Boštjan Šeruga, Eitan Amir
2018-04-11

Postmarketing Modifications of Drug Labels for Cancer Drugs Approved by the US Food and Drug Administration Between 2006 and 2016 With and Without Supporting Randomized Controlled Trials.

Alberto Ocana, Boštjan Šeruga, Eitan Amir, Hadar Goldvaser, Ariadna Tibau, Consolación Molto, Daniel Shepshelovich
2018-02-28

Role of cooperative groups and funding source in clinical trials supporting guidelines for systemic therapy of breast cancer

Fernando Andrés Pretel, Alberto Ocana, Arnoud J Templeton, Boštjan Šeruga, Eitan Amir, Ariadna Tibau, Geòrgia Anguera, Agusti Barnadas
2018-06

Medical oncology workload in Canada: infrastructure, supports, and delivery of clinical care

Richard Sullivan, Boštjan Šeruga, Wilma Hopman
2018-05-16

Meta-Research on Oncology Trials: A Toolkit for Researchers with Limited Resources

Boštjan Šeruga
2018-11-05

Adjuvant Radiation Therapy After Radical Nephrectomy in Patients with Localized Renal Cell Carcinoma: A Systematic Review and Meta-analysis

Alberto Ocana, Ian F. Tannock, Arnoud J Templeton, Boštjan Šeruga, Francisco Vera-Badillo, Eitan Amir, Galileo A Gonzalez-Conchas, David Hernández-Barajas, Adrian Verdines-Perez
2017-11-18

Reporting of Randomized Trials in Common Cancers in the Lay Media.

Alberto Ocana, Arnoud J Templeton, Boštjan Šeruga, Eitan Amir, Hadar Goldvaser, Domen Ribnikar
2017-08-24

Efficacy of extended adjuvant therapy with aromatase inhibitors in early breast cancer among common clinicopathologically-defined subgroups: A systematic review and meta-analysis.

Alberto Ocana, Arnoud J Templeton, Boštjan Šeruga, Eitan Amir, Hadar Goldvaser, Domen Ribnikar
2017-07-11

Influence of non-measurable disease on progression-free survival in patients with metastatic breast cancer

R Fazelzad, Alberto Ocana, Arnoud J Templeton, Boštjan Šeruga, Eitan Amir, Hadar Goldvaser, Domen Ribnikar
2017-02-28

Impact of Availability of Companion Diagnostics on the Clinical Development of Anticancer Drugs

Eitan Amir, Alberto Ocana, Beatriz Navarro Bravo, Eva Maria Galan-Moya, Arnoud J Templeton, Boštjan Šeruga, Atanasio Pandiella, Laura Díez-González, Ariadna Tibau
2017-05-12

Prognostic role of telomere length in malignancies: A meta-analysis and meta-regression

Alberto Ocana, Arnoud J Templeton, Boštjan Šeruga, Eitan Amir, Laura Díez-González
2017-04-09

Efficacy, safety, tolerability and price of newly approved drugs in solid tumors

Alberto Ocana, Beatriz Navarro Bravo, Arnoud J Templeton, Boštjan Šeruga, Eitan Amir, Tristan A Barnes
2017-12-15

Delivery of Global Cancer Care: An International Study of Medical Oncology Workload.

Richard Sullivan, Boštjan Šeruga, Wilma Hopman, Christopher M Booth, Manju Sengar
2017-10-31

Epidermal growth factor receptor overexpression and outcomes in early breast cancer: A systematic review and a meta-analysis.

Alberto Ocana, Ian F. Tannock, Arnoud J Templeton, Boštjan Šeruga, Francisco Vera-Badillo, Eitan Amir, Galileo A Gonzalez-Conchas, David Hernández-Barajas, Adrian Verdines-Perez
2016-03-10

Pretreatment Differences in Intraindividual Variability in Reaction Time between Women Diagnosed with Breast Cancer and Healthy Controls

Lori J. Bernstein, Christie Yao, Ian F. Tannock, Boštjan Šeruga
2016-12-01

Relevance of randomised controlled trials in oncology

Eitan Amir, Alberto Ocana, Ian F. Tannock, Arnoud J Templeton, Boštjan Šeruga, Francisco Vera-Badillo, Saroj Niraula
2016-05-05

Interaction between Hormonal Receptor Status, Age and Survival in Patients with BRCA1/2 Germline Mutations: A Systematic Review and Meta-Regression

Arnoud J Templeton, Alberto Ocana, Boštjan Šeruga, Atanasio Pandiella, Francisco Vera-Badillo, Eitan Amir, Laura Díez-González, Ariadna Tibau, Amirrtha Srikanthan, Robyn Goldstein
2016-02-10

Outcome of severe infections in afebrile neutropenic cancer patients

Boštjan Šeruga
2016-04-27

Under-reporting of harm in clinical trials

Alberto Ocana, Eitan Amir, Ian F. Tannock, Arnoud J Templeton, Boštjan Šeruga, Francisco Vera-Badillo
2016-08-05

Honorary and ghost authorship in reports of randomised clinical trials in oncology

Alberto Ocana, Eitan Amir, Monika K Krzyzanowska, Ian F. Tannock, Arnoud J Templeton, Boštjan Šeruga, Francisco Vera-Badillo, Shabbir Alibhai
2016-06-01

Oncologic Drugs Advisory Committee Recommendations and Approval of Cancer Drugs by the US Food and Drug Administration

Eitan Amir, Alberto Ocana, Arnoud J Templeton, Boštjan Šeruga, Ariadna Tibau, Geòrgia Anguera, Agusti Barnadas
2016-05-02

Bias in reporting of randomised clinical trials in oncology

Alberto Ocana, Eitan Amir, Monika K Krzyzanowska, Ian F. Tannock, Arnoud J Templeton, Boštjan Šeruga, Francisco Vera-Badillo, Shabbir Alibhai
2016-04-01

In silico analyses identify gene-sets, associated with clinical outcome in ovarian cancer: role of mitotic kinases

Alberto Ocana, Eitan Amir, Ana Alcaraz-Sanabria, Cristina Nieto-Jiménez, Arnoud J Templeton, Boštjan Šeruga, Atanasio Pandiella, Javier Pérez-Peña, Verónica Corrales-Sánchez

Human - wd:Q106120679

Welcome to Inventaire

the library of your friends and communities

learn more